Bajaj Healthcare Limited has announced a board meeting scheduled for May 8, 2026, in compliance with Regulation 29 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting will address key financial matters for the quarter and financial year ended March 31, 2026.

Board Meeting Agenda

The board of directors will convene to deliberate on two primary matters during the scheduled meeting:

Trading Window Restrictions

In accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct, Bajaj Healthcare has implemented trading restrictions for insiders and designated persons. The trading window closure details are as follows:

Regulatory Compliance

The announcement, dated May 02, 2026, was formally communicated to both major stock exchanges where the company's shares are listed. The notification ensures compliance with regulatory requirements for timely disclosure of material information to stakeholders and the investment community.

The company secretary and compliance officer, Monica Tanwar, has signed the official communication, emphasizing the company's commitment to maintaining transparency and adhering to regulatory guidelines throughout the financial results declaration process.

Bajaj healthcare has submitted its quarterly compliance certificate under SEBI regulations for the quarter ended March 31, 2026. The pharmaceutical company filed the mandatory documentation with both BSE and NSE on April 07, 2026, demonstrating its commitment to regulatory compliance.

Regulatory Compliance Filing

The compliance certificate was issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. This regulation requires companies to confirm proper handling of securities received from depository participants for dematerialization during each quarter.

Certificate Confirmation

MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, serves as the company's registrar and transfer agent. The firm issued the compliance certificate on April 3, 2026, confirming several key regulatory requirements were met during Q4FY26.

The certificate confirms that:

• Securities received from depository participants for dematerialization were properly accepted or rejected
• All securities were listed on stock exchanges where previously issued securities are traded
• Security certificates received for dematerialization were mutilated and cancelled after verification
• Depository names were substituted in the register of members within prescribed timelines

Corporate Governance

Monica Tanwar, serving as Company Secretary and Compliance Officer, digitally signed and submitted the compliance documentation. The filing demonstrates Bajaj Healthcare's adherence to corporate governance standards and regulatory requirements for listed companies.

This quarterly compliance filing represents standard regulatory practice for listed companies, ensuring transparency in securities handling and maintaining investor confidence through proper documentation and timely submissions to stock exchanges.